Lowenstein Sandler represented Applied Digital Corporation in the transaction. Applied Digital Corporation completed a committed equity facility of up to $250 million with YA II PN,...
Applied Digital’s $250 Million Committed Equity Facility
Applied Digital’s $53.2 Million Convertible Preferred Stock Issuance
Lowenstein represented Applied Digital in the transaction. Applied Digital completed a private financing arrangement with a single investor pursuant to which the company issued $53.2 million...
Phreesia’s Acquisition of Access eForms
Lowenstein Sandler represented Phreesia in the transaction. Phreesia, Inc. (NYSE: PHR), a leader in patient intake, outreach and activation, announced the acquisition of Access eForms, an...
ZyVersa Therapeutics’ Merger With Larkspur Health Acquisition Corp.
Lowenstein represented ZyVersa Therapeutics in the transaction, while Alston & Bird advised Larkspur Health Acquisition Corp. Manatt, Phelps & Phillips advised A.G.P./Alliance Global Partners. ZyVersa Therapeutics,...
Celldex Therapeutics’ $287.5 Million Common Stock Offering
Lowenstein Sandler represented Celldex Therapeutics in the offering. Celldex Therapeutics, Inc. (Celldex) (Nasdaq: CLDX) executed its $287.5 million public offering of common stock. Jefferies, SVB Leerink,...